|
|
 | | | |
- close
- close
- close
- close
StreetInsider.com
May 13
Comment
MoSys, Inc. (NASDAQ: MOSY) 7% LOWER; intends to offer shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be...
StreetInsider.com
May 13
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/pSivida+Corp.+%28PSDV%29+Posts+Q3+Loss+of+12cShare/8332031.html for the full story.
Benzinga
May 7
Comment
pSivida Corp. (NASDAQ: PSDV), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that ILUVIEN®, the first sustained release pharmaceutical product for the treatment of...
Benzinga
May 1
Comment
pSivida (NASDAQ: PSDV), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the U.S. Food and Drug Administration (FDA) acknowledged receipt of the resubmission of the...
Benzinga
Apr 29
Comment
pSivida Corp. (NASDAQ: PSDV), a specialty pharmaceutical company that
is a leader in the development of sustained release ophthalmic drug
treatments, today announced ILUVIEN® , the first sustained release
pharmaceutical product for the treatment...
StreetInsider.com
Apr 29
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/pSivida+%28PSDV%29+Affirms+Availability+of+Iluvien+in+U.K.+%28ALIM%29/8284290.html for the full story.
StreetInsider.com
Apr 10
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Ladenburg+Thalmann+Upgrades+pSivida+Corp.+%28PSDV%29+to+Buy/8243899.html for the full story.
StreetInsider.com
Apr 4
Comment
Alcatel-Lucent (NYSE: ALU) up 11.7%; Deutsche Bank upgraded from Hold to Buy, moving its price target from €1.00 to €1.80. Click here for more color.
pSivida Corp. (Nasdaq: PSDV) up 10.6%; announced that it has signed a funded technology...
Benzinga
Apr 4
Comment
pSivida Corp. (NASDAQ: PSDV), a specialty pharmaceutical company that
is a leader in the development of sustained release ophthalmic drug
treatments, today announced that it has signed a funded technology evaluation
agreement with a leading global...
Benzinga
Apr 1
Comment
pSivida Corp. (NASDAQ: PSDV), a specialty pharmaceutical company that
is a leader in the development of sustained release ophthalmic drug
treatments, today announced that its licensee Alimera Sciences, Inc. reported
the submission of its response...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_1/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
